2020
DOI: 10.1016/j.eururo.2020.06.023
|View full text |Cite
|
Sign up to set email alerts
|

Focus on the Quality of Prostate Multiparametric Magnetic Resonance Imaging: Synopsis of the ESUR/ESUI Recommendations on Quality Assessment and Interpretation of Images and Radiologists’ Training

Abstract: Objectives This study aims to define consensus-based criteria for acquiring and reporting prostate MRI and establishing prerequisites for image quality. Methods A total of 44 leading urologists and urogenital radiologists who are experts in prostate cancer imaging from the European Society of Urogenital Radiology (ESUR) and EAU Section of Urologic Imaging (ESUI) participated in a Delphi consensus process. Panellists completed two rounds of questionnaires with 55 items under three headings: image quality assess… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
19
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 34 publications
(19 citation statements)
references
References 27 publications
0
19
0
Order By: Relevance
“…A number of studies have reported significant variation in mp-MRI reporting amongst radiologists, uninfluenced by experience measured either in years or in the number of mp-MRI examinations reported, suggesting that experience does not necessarily reflect expertise [16][17][18][19][20][21]25]. Additionally, variation in MRI acquisition and quality of images will further influence diagnostic accuracy at an institutional level [29]. In a recent statement, the European Society of Urogenital Radiology and European Association of Urology Section of Urologic Imaging recommended that MRI image quality be checked and reported [30].…”
Section: Discussionmentioning
confidence: 99%
“…A number of studies have reported significant variation in mp-MRI reporting amongst radiologists, uninfluenced by experience measured either in years or in the number of mp-MRI examinations reported, suggesting that experience does not necessarily reflect expertise [16][17][18][19][20][21]25]. Additionally, variation in MRI acquisition and quality of images will further influence diagnostic accuracy at an institutional level [29]. In a recent statement, the European Society of Urogenital Radiology and European Association of Urology Section of Urologic Imaging recommended that MRI image quality be checked and reported [30].…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, mpMRI shows a pooled NPV of 91% (86%–94%), 32,33 the variation is mostly related to non‐comparable PCa prevalence among countries and to different definitions of csPCa. Also, it is thought to be due to different centers’ expertise and lack of general quality standards 34,35 . The clinical benefit of prostate MRI comes from its NPV to rule‐out csPCa that allows biopsy avoidance and reduces the detection of ciPCa.…”
Section: The Mri Pathwaymentioning
confidence: 99%
“…PI‐QUAL might offer clinicians a scoring system for evaluating and reporting the quality of their prostate MRI scans. De Rooij et al 34,35 released a list of consensus statements on MRI images quality. Recommendations included checking and reporting on image quality, to visually assess images adequacy for determining diagnostic acceptability, to control image quality at 6 months intervals or in 5% of studies, and to standardize ADC measurements on phantom.…”
Section: The Mri Pathwaymentioning
confidence: 99%
“…The latter being image quality, image read-outs, and data processing. Because radiologists have direct control of MRI, they can point to multiple advances including technologies that improve the speed and consistencies of MRI acquisitions, uniform image interpretation criteria [16], certification efforts [17], quality checks scores [18], and recent advances in automated gland contouring and suspicion lesion heat-maps using deep learning techniques [19].…”
mentioning
confidence: 99%
“…Secondly, measurements, control, and assurance of the sources of variability should be undertaken, such as compliance with technical standards [30], image quality assessment scores [18], inter-and intra-reader/center variability [31], and cancer detection rates (including underdiagnosis cancer rates). Third, we need to develop performance measures for the main individuals participating in the MRI biopsy pathway including radiologists, urologists, and pathologists (and others), ultimately laying down the foundations for the certification of the main players, once tolerances are known [17]. Finally, key performance indices for diagnostic units on their ability to effectively deliver a high-quality service need to be developed, as part of accreditation processes focusing on team working outputs.…”
mentioning
confidence: 99%